2017 -
2023 External Manufacturing and CDMO Lead @
2004 -
2017 Director of Bioservices, BB50 Manufacturing @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company
Christopher Klem Education
Aspen University
Master of Business Administration - MBA (Pharmaceutical Management)
2016
-
2021
Rutgers University
B.A. (Economics)
1987
-
1992
Christopher Klem Skills
Technology Transfer
cGMP
Biopharmaceuticals
GMP
Validation
FDA
Leadership
Biotechnology
Microsoft Office
Customer Service
Strategy
Christopher Klem Summary
Christopher Klem, based in Frenchtown, NJ, US, is currently a Vice President, Commercial Manufacturing at enGene. Christopher Klem brings experience from previous roles at Asklepios BioPharmaceutical, Inc. (AskBio), Spark Therapeutics, Inc. and ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company. Christopher Klem holds a 2016 - 2021 Master of Business Administration - MBA in Pharmaceutical Management @ Aspen University. With a robust skill set that includes Technology Transfer, cGMP, Biopharmaceuticals, GMP, Validation and more. Christopher Klem has 2 emails and 1 mobile phone numbers on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.